[
    [
        {
            "time": "",
            "original_text": "强者不再恒强，Q3医药也有“弟弟”",
            "features": {
                "keywords": [
                    "医药",
                    "Q3",
                    "强者",
                    "弟弟"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "强者不再恒强，Q3医药也有“弟弟”",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司13价肺炎结合疫苗正在摩洛哥进行注册申报",
            "features": {
                "keywords": [
                    "沃森生物",
                    "13价肺炎结合疫苗",
                    "摩洛哥",
                    "注册申报"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司13价肺炎结合疫苗正在摩洛哥进行注册申报",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04",
            "original_text": "沃森生物：子公司玉溪沃森生物技术有限公司于2021年4月与摩洛哥MarocVax Sarl公司就玉溪沃森生产的13价肺炎球菌多糖结合疫苗在摩洛哥的成品进口、分销、销售及其原液供应合作业务签订了独家经销协议",
            "features": {
                "keywords": [
                    "沃森生物",
                    "玉溪沃森",
                    "摩洛哥",
                    "独家经销协议",
                    "13价肺炎球菌多糖结合疫苗"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：子公司玉溪沃森生物技术有限公司于2021年4月与摩洛哥MarocVax Sarl公司就玉溪沃森生产的13价肺炎球菌多糖结合疫苗在摩洛哥的成品进口、分销、销售及其原液供应合作业务签订了独家经销协议",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司新冠mRNA疫苗三期临床研究等相关的工作在正常推进中",
            "features": {
                "keywords": [
                    "沃森生物",
                    "新冠mRNA疫苗",
                    "三期临床研究"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司新冠mRNA疫苗三期临床研究等相关的工作在正常推进中",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：疫苗产品属于特殊商品，公司不能直接将疫苗产品卖给最终消费者",
            "features": {
                "keywords": [
                    "沃森生物",
                    "疫苗产品",
                    "特殊商品"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：疫苗产品属于特殊商品，公司不能直接将疫苗产品卖给最终消费者",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司与清华大学、天津医科大学合作研发的两个疫苗目前正开展二期临床试验",
            "features": {
                "keywords": [
                    "沃森生物",
                    "清华大学",
                    "天津医科大学",
                    "疫苗",
                    "二期临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司与清华大学、天津医科大学合作研发的两个疫苗目前正开展二期临床试验",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：子公司上海泽润九价HPV疫苗正在开展Ⅲ期临床研究的各项前期准备工作",
            "features": {
                "keywords": [
                    "沃森生物",
                    "上海泽润",
                    "九价HPV疫苗",
                    "Ⅲ期临床研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：子公司上海泽润九价HPV疫苗正在开展Ⅲ期临床研究的各项前期准备工作",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司与清华大学、天津医科大学合作研发的重组新型冠状病毒疫苗（黑猩猩腺病毒载体）、子公司上海泽润研发的重组新型冠状病毒疫苗（CHO细胞）目前正在开展二期临床试验",
            "features": {
                "keywords": [
                    "沃森生物",
                    "清华大学",
                    "天津医科大学",
                    "重组新型冠状病毒疫苗",
                    "二期临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司与清华大学、天津医科大学合作研发的重组新型冠状病毒疫苗（黑猩猩腺病毒载体）、子公司上海泽润研发的重组新型冠状病毒疫苗（CHO细胞）目前正在开展二期临床试验",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物、天宇股份涨超10%，生物医药ETF（512290）涨超3.5%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "天宇股份",
                    "生物医药ETF",
                    "涨超10%",
                    "涨超3.5%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物、天宇股份涨超10%，生物医药ETF（512290）涨超3.5%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "新能源主线继续领跑，机构建议布局“跨年行情”",
            "features": {
                "keywords": [
                    "新能源",
                    "跨年行情"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "新能源主线继续领跑，机构建议布局“跨年行情”",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]